Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 13, 2022

SELL
$55.7 - $145.79 $295,042 - $772,249
-5,297 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$135.05 - $182.59 $357,072 - $482,767
-2,644 Reduced 33.3%
5,297 $789,000
Q3 2021

Nov 12, 2021

BUY
$145.58 - $192.14 $14,558 - $19,214
100 Added 1.28%
7,941 $1.16 Million
Q2 2021

Aug 12, 2021

BUY
$134.22 - $202.37 $254,346 - $383,491
1,895 Added 31.87%
7,841 $1.54 Million
Q1 2021

May 13, 2021

BUY
$140.25 - $196.86 $217,527 - $305,329
1,551 Added 35.29%
5,946 $1.08 Million
Q4 2020

Feb 09, 2021

BUY
$126.47 - $163.7 $555,835 - $719,461
4,395 New
4,395 $622,000

Others Institutions Holding TXG

About 10x Genomics, Inc.


  • Ticker TXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 95,046,400
  • Market Cap $1.36B
  • Description
  • 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...
More about TXG
Track This Portfolio

Track Blair William & CO Portfolio

Follow Blair William & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Blair William & CO, based on Form 13F filings with the SEC.

News

Stay updated on Blair William & CO with notifications on news.